PERSPECTIVE article
Front. Oncol.
Sec. Cancer Metabolism
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1615491
Co-morbid diabetes mellitus in cancer patients undergoing treatment: A case series and perspective
Provisionally accepted
- 1R.V. College of Engineering (RVCE), Bengaluru, Karnataka, India
- 2Sammprada cancer hospital, Bangalore, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Diabetes mellitus (DM) is frequently diagnosed among cancer patients on treatment, which suggests a concomitant underlying mechanism. DM is found among 8 to 18% of cancer patients. The initiation of cancer treatment is linked with the onset of diabetes. This study aims to assess the variation in blood glucose levels of cancer patients during the course of their treatment. Methods: A hospital record based cross-sectional study was conducted from November 2024 to January 2025, among 50 cancer patients on treatment at Sammprada cancer hospital, Bangalore, India. From the initial 50 cancer patients, a series of 11 cases with large variation in blood glucose levels were included in the study. These include new onset or old cases of diabetes, with blood glucose levels measured across 6 timeframes during the course of cancer treatment.Results: For the initial 50 patients, the measure of central tendency seemed regressed to the mean. Hence, the design of study was changed from cross-sectional to a case series. For the series of 11 patients all of whom had advanced stage cancer, 5 patients (2 males, 3 females) had history of diabetes and 2 female patients were incident cases of diabetes (1 each in endocrine and cervical cancer). Also, the treatment for diabetes was revised or newly initiated for a total of 5 patients (4 females, 1 male). Conclusion: Healthcare providers should regularly screen the levels of blood glucose during the continuum of cancer care and monitor the change in trend.
Keywords: chemotherapy, Diabetes Mellitus, Hyperglycemia, hyperinsulinemia, neoplasm
Received: 21 Apr 2025; Accepted: 23 Jun 2025.
Copyright: © 2025 HUV, Rao, Ramani and Naik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Vinod Ramani, Sammprada cancer hospital, Bangalore, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.